Banerjee Rahul, Tsiapali Ekaterini
Department of Internal Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Medstar Regional Breast Health Program at Medstar Southern Maryland Hospital Center, Department of Surgery, Georgetown University, Washington, DC, USA.
Support Care Cancer. 2016 Jan;24(1):163-171. doi: 10.1007/s00520-015-2758-x. Epub 2015 May 13.
Fertility preservation is an important issue for premenopausal cancer patients; however, not all patients receive counseling about chemotherapy-induced infertility and potential mitigation strategies. We aimed to identify characteristics of premenopausal breast cancer patients less likely to receive fertility counseling. We also investigated patient recall of chart-documented fertility discussions and patient attitudes toward fertility preservation.
The study was approved by our institution's Institutional Review Board. All female patients with invasive primary breast cancer of any type, aged 40 or younger at the time of diagnosis, who were diagnosed during or up to 5 years prior to the study period were eligible. The study was conducted between February 2012 and October 2013. Enrolled patients completed an anonymous survey, and their medical charts were subsequently reviewed to identify provider documentation of fertility discussions, referral to fertility specialists, or implementation of fertility preservation. Patient comments regarding their fertility were solicited and examined thematically.
Forty-nine patients consented to participate. Fertility discussions were documented by providers in 55% of patients. Patients aged over 35 and multiparous patients were significantly less likely than their counterparts (p < 0.01 in both cases) to have had chart-documented fertility discussions. Only 52% of patients with chart-documented discussions recalled having had such a conversation. Patient comments highlighted the difficulty of considering fertility at the time of diagnosis and also the risks and obstacles facing fertility preservation.
Despite increasing awareness, fertility is not universally discussed with premenopausal breast cancer patients at the time of diagnosis; older and multiparous patients are at particular risk of not receiving fertility counseling. Even when such discussions are documented, only about half of patients recall the conversation. Patient-reported barriers to fertility preservation include lack of education combined with the stress of diagnosis, financial costs, and perceived treatment toxicities.
生育力保存是绝经前癌症患者的一个重要问题;然而,并非所有患者都接受过关于化疗导致不孕及潜在缓解策略的咨询。我们旨在确定不太可能接受生育咨询的绝经前乳腺癌患者的特征。我们还调查了患者对病历记录的生育相关讨论的回忆情况以及患者对生育力保存的态度。
本研究经我们机构的机构审查委员会批准。所有诊断时年龄在40岁及以下、患有任何类型原发性浸润性乳腺癌、在研究期间或研究期前5年内被诊断的女性患者均符合条件。研究于2012年2月至2013年10月进行。入选患者完成一份匿名调查问卷,随后对其病历进行审查,以确定医护人员关于生育相关讨论的记录、转介至生育专家或生育力保存措施的实施情况。征求患者关于其生育情况的意见并进行主题分析。
49名患者同意参与。医护人员在55%的患者病历中记录了生育相关讨论。年龄超过35岁的患者和经产妇比其他患者显著更不可能有病历记录的生育相关讨论(两种情况p均<0.01)。在有病历记录讨论的患者中,只有52%回忆起有过这样的谈话。患者的意见强调了在诊断时考虑生育的困难,以及生育力保存面临的风险和障碍。
尽管意识不断提高,但绝经前乳腺癌患者在诊断时并非都普遍接受生育相关讨论;年龄较大和经产妇尤其有不接受生育咨询的风险。即使有此类讨论的记录,也只有约一半的患者记得有过这样的谈话。患者报告的生育力保存障碍包括缺乏相关知识以及诊断带来的压力、经济成本和感知到的治疗毒性。